IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 409 India’s cumulative vaccination coverage over 177.67 Crore More than 15 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 177.67 Crore (1,77,67,18,549) today. More than 15 lakh (15,93,931Vaccine Doses have been administered till 7 pm today. More than 2 Crore (2,00,84,507) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401595
2nd Dose 9967653
Precaution Dose 4180854
FLWs 1st Dose 18409542
2nd Dose 17443191
Precaution Dose 6231673
Age Group 15-18 years 1st Dose 54876416
  2nd Dose 27909986
Age Group 18-44 years 1st Dose 551851680
2nd Dose 444586761
Age Group 45-59 years 1st Dose 202278996
2nd Dose 180231553
Over 60 years 1st Dose 126416262
2nd Dose 112260407
Precaution Dose 9671980
Cumulative 1st dose administered 964234491
Cumulative 2nd dose administered 792399551
Precaution Dose 20084507
Total 1776718549

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 28th February, 2022 (409th Day)
HCWs 1st Dose 58
2nd Dose 1244
Precaution Dose 9703
FLWs 1st Dose 88
2nd Dose 1800
Precaution Dose 14220
Age Group 15-18 years 1st Dose 80632
  2nd Dose 415912
Age Group 18-44 years 1st Dose 99085
2nd Dose 670285
Age Group 45-59 years 1st Dose 14290
2nd Dose 142336
Over 60 years 1st Dose 12802
2nd Dose 83149
Precaution Dose 48327
Cumulative 1st dose administered 206955
Cumulative 2nd dose administered 1314726
Precaution Dose 72250
Total 1593931

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker